Q1 2025 SI-BONE Inc Earnings Call Transcript
Key Points
- SI-BONE Inc (SIBN) reported a strong start to 2025 with worldwide revenue reaching $47.3 million, representing approximately 25% growth.
- The company achieved positive adjusted EBITDA in the quarter, highlighting strong financial performance.
- SI-BONE Inc (SIBN) experienced a 27% growth in US revenue, driven by broad-based demand and rapid adoption of new solutions.
- The company added a record number of physicians, with a 27% increase in its physician base, indicating strong market penetration.
- SI-BONE Inc (SIBN) has a robust pipeline of innovative products, including new solutions expected to launch over the next 12 to 18 months, which are anticipated to drive further growth.
- Operating expenses grew by 7.8%, primarily due to higher commissions and R&D investments, which could impact profitability if not managed carefully.
- The company reported a net loss of $6.5 million, although this was an improvement from the previous year.
- There is potential pressure on gross margins due to the cost of new product launches and the depreciation of surgical capacity and software costs.
- SI-BONE Inc (SIBN) faces macroeconomic uncertainties, which could impact future demand and financial performance.
- The company is cautious about potential headwinds and has maintained the lower end of its revenue guidance, indicating a conservative outlook.
Good afternoon, and welcome to SI-BONE's first-quarter 2025 earnings conference call. (Operator Instructions) As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to Saqib Iqbal, Vice President, FP&A and Investor Relations at SI-BONE for a few introductory comments. Please go ahead.
Earlier today, SI-BONE released financial results for the quarter ended March 31, 2025. A copy of the press release is available on the company's website. Before we begin, I'd like to remind you that management's remarks today may include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties including those set forth in our SEC filings such as our most recent Form 10-K, and actual results might differ materially from any forward-looking statement that we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
